lobbying_activities: 1381031

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1381031	8bf56eba-0b68-48ef-a5c8-56ad3163cf8b	Q1	AMERICAN ASSOCIATION OF NURSE PRACTITIONERS	401040928	AMERICAN ASSOCIATION OF NURSE PRACTITIONERS	2013	first_quarter	PHA	Legislation and policies relating to: FDA Drug Safety and Risk Management Advisory Committee January 25 recommendation to reschedule hydrocodone as a Schedule II controlled substanceH.R. 1285 To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug S. 621 - Safe Prescribing Act	Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),Office of Management & Budget (OMB),SENATE,White House Office		43392	0	0	2013-04-19T12:10:55.853000-04:00